Organon & Co (OGN) Earnings Date & Reports

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OGN is expected to report earnings to fall 8.22% to 93 cents per share on August 12

Q2'25

Est.

$0.94

Q1'25

Beat

by $0.11

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.04

The last earnings report on May 01 showed earnings per share of $1.02, beating the estimate of 91 cents. With 837.96K shares outstanding, the current market capitalization sits at 4.73B.

View a ticker or compare two or three

Compare

OGN